GCP
ADCT icon

GSA Capital Partners’s ADC Therapeutics ADCT Stock Holding History

GSA Capital Partners’s Portfolio ADCT Stock Details ADCT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-20,889
Closed -$74K – 1671
2025
Q4 		$74K Buy
+20,889
New +$84.8K 0.01% 1555
2023
Q4 		– Sell
-121,897
Closed -$109K – 1447
2023
Q3 		$109K Buy
121,897
+13,012
+12% +$17.3K 0.01% 1377
2023
Q2 		$234K Buy
108,885
+85,237
+360% +$192K 0.02% 1181
2023
Q1 		$46K Buy
+23,648
New +$87.2K ﹤0.01% 1404

Other funds holding ADCT

RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $3.5B AUM 1,165.83% 1-Year Est. Return
PM
Prosight Management Dallas, Texas $610M AUM 40.86% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
EAM
Eventide Asset Management Boston, Massachusetts $6.05B AUM 76.64% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $1.6B AUM 121.58% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $57.5B AUM 55.25% 1-Year Est. Return
Millennium Management
Millennium Management New York $134B AUM 35.51% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $761B AUM 31.28% 1-Year Est. Return